top of page
gradientForSurfBreak.png

Item List

Cision PR Newsire
Strados Labs forms collaboration with Boehringer Ingelheim for its Idiopathic Pulmonary Fibrosis (IPF) Pilot Study

Strados Labs today announced a collaboration with Boehringer Ingelheim to remotely monitor patients using its FDA-cleared pulmonary wearable device in an upcoming idiopathic pulmonary fibrosis (IPF) pilot study. In Boehringer Ingelheim's pilot study, the Strados RESP Biosensor will be used to monitor cough and crackles in IPF patients at home aiming to accelerate the development of much needed new therapies for people living with IPF.

Recent Posts

Portfolio Company

Carlsmed.png

AI skin cancer detection deployed to over 200,000 patients ...

Med-Tech Insights

Portfolio Company

Carlsmed.png

Using AI for the Medical Note: Game Changer or a Bridge Too Far? ...

AJMC

Portfolio Company

Carlsmed.png

SeqOnce Biosciences - Expands Their Pathogen Assay Suite with the Addition of RT ...

Cision PR Newswire

surf break copy_edited_edited.jpg
surbreak-19.png
WM360_logo-18.png
bottom of page